National Institute of Dental and Craniofacial Research; Notice of Closed Meetings, 56076-56077 [2022-19730]
Download as PDF
<![CDATA[
56076
Federal Register / Vol. 87, No. 176 / Tuesday, September 13, 2022 / Notices
evaluation of the extension of the
Certified Community Behavioral Health
Clinic (CCBHC) demonstration program.
Section 223 of the Protecting Access
to Medicare Act (Pub. L. 113–93;
PAMA) authorized the CCBHC
demonstration to allow states to test a
new strategy for delivering and
reimbursing a comprehensive array of
services provided in community
behavioral health clinics. The
demonstration aims to improve the
availability, quality, and outcomes of
outpatient services provided in these
clinics by establishing a standard
definition for CCBHCs and develops a
new Medicaid prospective payment
system (PPS) in each state that accounts
for the total cost of providing nine types
of services to all people who seek care.
The PPS in each state is designed to
provide CCBHCs with the financial
support and stability necessary to
the federal and state costs of a full range
of mental health services (including
inpatient, emergency, and ambulatory
services). The ability of ASPE to provide
this information to Congress requires a
rigorously designed and independent
evaluation of the CCBHC demonstration.
The information collected under this
submission will help ASPE address
research questions for the evaluation
and inform required reports to Congress.
ASPE is requesting approval of this
information collection for a three-year
period. Information will be collected
from individuals (CCBHC clients),
businesses (CCBHC staff) and from state
governments.
The total annual burden hours
estimated for this information collection
request are summarized in the table
below.
deliver these required services. The
demonstration also aims to incentivize
quality through quality bonus payments
to clinics and requires CCBHCs to report
quality measures and costs.
Need and Proposed Use of the
Information: PAMA mandates that HHS
submit reports to Congress about the
Section 223 demonstration that assess
(1) access to community-based mental
health services under Medicaid in the
area or areas of a state targeted by a
demonstration program as compared to
other areas of the state, (2) the quality
and scope of services provided by
certified community behavioral health
clinics as compared to communitybased mental health services provided
in states not participating in a
demonstration program and in areas of
a demonstration state that are not
participating in the demonstration, and
(3) the impact of the demonstration on
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Type of respondent
Average
burden
per response
(in hours)
Total
burden hours
State official interviews ....................................................................................
CCBHC leadership interviews .........................................................................
CCBHC client focus groups .............................................................................
CCBHC survey ................................................................................................
27
10
14
50
1
1
1
1
1
1
1
3
27
10
14
150
Total ..........................................................................................................
101
........................
........................
201
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2022–19757 Filed 9–12–22; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental and
Craniofacial Research; Notice of
Closed Meetings
jspears on DSK121TN23PROD with NOTICES
Number
responses per
respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
17:30 Sep 12, 2022
Jkt 256001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; DSR Member Conflict.
Date: October 14, 2022.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Aiwu Cheng, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
National Institute of Dental and Craniofacial
Research, National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892,
Aiwu.cheng@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Clinical Studies.
Date: October 27, 2022.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Yun Mei, MD, Scientific
Review Officer, Scientific Review Branch,
National Institute of Dental and Craniofacial
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Research, National Institutes of Health, 6701
Democracy Boulevard, Suite #670, Bethesda,
MD 20892, (301) 827–4639, yun.mei@
nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; In Utero Treatments of
Congenital Dental and Craniofacial Disorders
Using Precision Medicine Approaches.
Date: October 28, 2022.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Aiwu Cheng, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
National Institute of Dental and Craniofacial
Research, National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892,
Aiwu.cheng@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS.)
E:\FR\FM\13SEN1.SGM
13SEN1
Federal Register / Vol. 87, No. 176 / Tuesday, September 13, 2022 / Notices
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19730 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jspears on DSK121TN23PROD with NOTICES
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Career Development
(Ks) and Conference support (R13) Review.
Date: October 25, 2022.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tianhong Wang, Ph.D.,
MD, Scientific Review Officer, National
Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health,
6707 Democracy Blvd., Bethesda, MD 20892,
(301) 435–1189, wangt3@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: September 7, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19674 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Cancer Institute; Notice of
Meeting
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Council of Research Advocates.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Council of Research Advocates.
Date: September 28, 2022.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: Welcome and Chairwoman’s
Remarks, NCI Acting Director’s Update, NCI
Updates and Legislative Update.
Place: National Institutes of Health, 9000
Rockville Pike, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Amy Williams, Acting
Director, NCI Office of Advocacy Relations,
National Cancer Institute, NIH, 9000
Rockville Pike, Building 31, Room 10A28,
Bethesda, MD 20892, (240) 781–3406,
williaam@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: NCRA: https://
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, sOffice of Federal Advisory
Committee Policy.
[FR Doc. 2022–19729 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:30 Sep 12, 2022
Jkt 256001
56077
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Genomic Fields to Enhance Diversity.
Date: November 7, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3189, Bethesda, MD 20892, (301) 435–
1580, mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Computational Genomics and Data
Science.
Date: November 17, 2022.
Time: 3:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3189, Bethesda, MD 20892, (301) 435–
1580, mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; T32 Genomic Training.
Date: November 18, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
E:\FR\FM\13SEN1.SGM
13SEN1
]]>Agencies
[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Pages 56076-56077]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19730]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental and Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; DSR Member Conflict.
Date: October 14, 2022.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental and Craniofacial Research,
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aiwu Cheng, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities,
National Institute of Dental and Craniofacial Research, National
Institutes of Health, 6701 Democracy Blvd., Bethesda, MD 20892,
[email protected].
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; Clinical Studies.
Date: October 27, 2022.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental and Craniofacial Research,
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yun Mei, MD, Scientific Review Officer,
Scientific Review Branch, National Institute of Dental and
Craniofacial Research, National Institutes of Health, 6701 Democracy
Boulevard, Suite #670, Bethesda, MD 20892, (301) 827-4639,
[email protected].
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; In Utero Treatments of Congenital
Dental and Craniofacial Disorders Using Precision Medicine
Approaches.
Date: October 28, 2022.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental and Craniofacial Research,
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aiwu Cheng, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities,
National Institute of Dental and Craniofacial Research, National
Institutes of Health, 6701 Democracy Blvd., Bethesda, MD 20892,
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health,
HHS.)
[[Page 56077]]
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19730 Filed 9-12-22; 8:45 am]
BILLING CODE 4140-01-P
